title: A maintenance dose of atazanavir/ritonavir 200/100 mg once daily is effective in virologically suppressed HIV-1-infected patients.
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Lanzafame
authors.forename: Emanuela
authors.initials: E
authors.lastname: Lattuada
authors.forename: Fabio
authors.initials: F
authors.lastname: Rigo
authors.forename: Sandro
authors.initials: S
authors.lastname: Vento
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009842:Oligopeptides / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D011725:Pyridines / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D019438:Ritonavir / Q000008:administration & dosage* / Q000493:pharmacokinetics*
chemical_list: D019380:Anti-HIV Agents; D009842:Oligopeptides; D011725:Pyridines; D019438:Ritonavir